% Expired Patents = 100.0

EPO Patents = 5

Forward Citations = 19

Loading Chart...

5 inventors (with patents filed for the assignee):

Andrew J Turner (2 out of 15 patents)

Christopher P Prior (1 out of 9 patents)

Homayoun Sadeghi (1 out of 8 patents)

4. Baiyang Wang (1 out of 3 patents)

5. David James Ballance (1 out of 19 patents)

6. Char-Huei Lai (0 patent)

7. Andrew John Turner (0 patent)

8. Andrew John Turner (0 patent)

9. Christopher Philip Prior (0 patent)

2 patents: Sort by Forward Citations

1. 8822639 - Transferrin fusion protein libraries (2014-09-02),

2. 8158579 - Fusion protein of an exendin to modified transferrin (2012-04-17),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

2 Patents

#2,217 in New York, NY

#5,852 in New York

#94,841 in US

New York, NY, United States of America

Biorexis Pharmaceutical Corporation

Forward Citations = 19

5 inventors:

Andrew J Turner (2 out of 15 patents)

Christopher P Prior (1 out of 9 patents)

Homayoun Sadeghi (1 out of 8 patents)

4. Baiyang Wang (1 out of 3 patents)

5. David James Ballance (1 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biorexis Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/biorexis-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]